Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 8, 2011

Premium

Marina Biotech has announced a number of organizational changes.

The company said that Richard Ho, previously senior medical director of Entelos, has joined Marina as executive vice president of research and development.

CFO Peter Garcia has resigned and will be replaced by Philip Ranker, formerly CFO of Suneva Medical.

Barry Polisky has stepped down as Marina's CSO and will become a distinguished scientist and chairman of the company's scientific advisory panel. Alan Dunton, who founded pharmaceutical consulting firm Danerius, has been hired as the company's new CSO.

Lastly, Michael Templin, Marina's senior vice president of preclinical development, has been promoted to senior vice president and CTO.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.